A method for detecting the content of disodium edetate in cetirizine hydrochloride eye drops
The disodium yedate content in cetirizine hydrochloride eye drops was detected by high performance liquid chromatography analysis method, which solved the problems of detection error and interference of auxiliary materials in the prior art, and achieved high accuracy and repeatability detection effect.
Patent Information
- Application Number
- CN202411366986.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-29
- Publication Date
- 2024-11-29
- Estimated Expiration
- 2044-09-29
AI Technical Summary
The existing detection method for disodium ydelic acid content in cetirizine hydrochloride eye drops is prone to errors, and due to the large number of auxiliary materials, the interference between the auxiliary materials during the complexing of the sample will lead to poor detection methods. The accuracy is low, and the amount of disodium yedate cannot be accurately detected.
The content of disodium ydelic acid in cetirizine hydrochloride eye drops was detected by high performance liquid chromatography analysis method. By selecting the appropriate mobile phase and pH value, there is no need to perform complexation pretreatment of the reference solution and the test sample solution. The content of disodium ydenamate was calculated by using a Poroshell HPH-C18 chromatography column and 0.8-0.9 g/L tetrabutyl ammonium bisulfate as the mobile phase.
It realizes detection without pre-complexing processing, improves the accuracy and repeatability of the detection, reduces errors, simplifies sample preparation, improves the specificity and reliability of the detection, and saves detection costs.
Smart Images

Figure CN118883776B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of drug analysis, and in particular relates to a method for detecting the content of disodium edetate in cetirizine hydrochloride eye drops. Background Art
[0002] Cetirizine hydrochloride is a histamine H1 receptor antagonist, clinically used for seasonal and perennial allergic rhinitis, rhinocorticitis, urticaria and other symptoms. It is easily soluble in water, soluble in methanol or ethanol, and almost insoluble in chloroform or acetone. Its chemical structure is shown below: .
[0003] Edetate disodium is often used in preparations because of its metal chelating properties. In the process of generic drug development, in order to ensure that the amount of excipients in the generic drug is consistent with that in the reference preparation, it is necessary to reverse analyze the amount of edetate disodium in the reference preparation and measure the content of edetate disodium in the self-developed preparation. At present, the commonly used method for detecting the content of disodium edetate in preparations is to use ferric chloride or copper sulfate and other complexing agents to complex the preparations, and then use an ultraviolet detector to determine the content. For example, CN111398443A discloses a method for determining disodium edetate in tafluprost eye drops, which uses copper chloride to pre-treat the reference solution and the test solution, and then determines the content of disodium edetate; CN114487192A discloses a method for determining the content of disodium edetate in desloratadine oral solution, which uses ferric chloride to pre-treat the reference solution and the test solution, and then determines the content of disodium edetate; CN116482259A discloses a method for determining the content of disodium edetate in metronidazole gel, which uses ferric chloride hexahydrate to pre-treat the reference solution and the test solution, and then determines the content of disodium edetate. This series of methods involves performing a series of complexation pre-treatments on the reference solution and the test solution before determining the content of disodium edetate, which is prone to detection errors. In addition, there are many excipients in cetirizine hydrochloride eye drops, and the sample complexation treatment will cause interference between the excipients, resulting in poor specificity of the detection method and low accuracy, making it impossible to accurately and quantitatively detect the content of disodium edetate in the product.
[0004] Therefore, the art needs to provide a method for detecting the content of disodium edetate in cetirizine hydrochloride eye drops, which does not require complexation pre-treatment of the reference solution and the test solution and has strong specificity, good repeatability, and is simple and rapid. Summary of the invention
[0005] The present invention aims to provide a method for detecting the content of disodium edetate in cetirizine hydrochloride eye drops, which does not require complexation pretreatment of a reference solution and a test solution and has strong specificity, good repeatability, and is simple and rapid.
[0006] On the one hand, the present invention provides a method for detecting the content of disodium edetate in cetirizine hydrochloride eye drops, wherein the cetirizine hydrochloride eye drops are analyzed by a high performance liquid chromatography analysis method to obtain a chromatogram, and based on the chromatogram, the content of disodium edetate in the cetirizine hydrochloride eye drops is determined, wherein the mobile phase A used in the high performance liquid chromatography is a 0.8-0.9 g / L tetrabutylammonium hydrogen sulfate solution.
[0007] In some embodiments, the pH value of the mobile phase A is 9.5-10.5.
[0008] In some embodiments, the pH value of the mobile phase A is adjusted using aqueous ammonia.
[0009] It can be understood that the applicant has screened out a suitable mobile phase A and the pH value of the mobile phase A through a lot of creative work. Under the conditions of the mobile phase and the pH value of the mobile phase, the content of disodium edetate in cetirizine hydrochloride eye drops can be accurately detected without the need for complexation pre-treatment of the cetirizine hydrochloride eye drops reference solution and the test solution.
[0010] In some embodiments, the chromatographic column used in the high performance liquid chromatography is Poroshell HPH-C18, 3.0 mm×100 mm, 2.7 μm.
[0011] In some embodiments, the cetirizine hydrochloride eye drops are provided in the form of a test solution, wherein the test solution is an aqueous solution of cetirizine hydrochloride eye drops, and based on each milliliter of the test solution, the concentration of disodium edetate is 25 μg / mL.
[0012] In some embodiments, the detection of the content of disodium edetate in the cetirizine hydrochloride eye drops also requires providing a reference solution, wherein the reference solution is an aqueous solution of disodium edetate, and based on each milliliter of the reference solution, the concentration of disodium edetate is 25 μg / mL.
[0013] It can be understood that the test solution is an aqueous solution of cetirizine hydrochloride eye drops, and the reference solution is an aqueous solution of disodium edetate. There is no need to perform complexation pre-treatment on the sample as in the prior art, which simplifies the preparation method of the test solution and the reference solution, reduces the interference of the complexing agent on the auxiliary materials in the test solution, reduces the possibility of error generation, and can more accurately quantitatively detect the content of disodium edetate in the test solution.
[0014] In some embodiments, the detection wavelength used in the high performance liquid chromatography is 214 nm.
[0015] In some embodiments, the column temperature used in the HPLC is 20°C.
[0016] In some embodiments, the elution gradient used in the high performance liquid chromatography is:
[0017] .
[0018] In some embodiments, based on the chromatogram, the content of disodium edetate in the cetirizine hydrochloride eye drops is determined by calculating the peak area external standard method, and the calculation formula is as follows:
[0019] ,
[0020] A S : Peak area of disodium edetate in the test solution, M R1 :Sampling amount of reference substance / mg, C R :Content of reference substance, N S :Dilution multiple of test solution, A R1 :The average peak area of edetate disodium after 5 consecutive injections of the reference solution, M S : Sample volume of the test sample / mL, N R : Dilution multiple of reference solution.
[0021] In the second aspect of the present invention, a method for detecting the content of disodium edetate in cetirizine hydrochloride eye drops is more specifically proposed, comprising:
[0022] (1) Chromatographic conditions
[0023] Chromatographic column: Poroshell HPH-C18, 3.0mm×100mm, 2.7μm,
[0024] Detector: DAD,
[0025] Detection wavelength: 214nm,
[0026] Column temperature: 20°C,
[0027] Mobile phase A: 0.8-0.9 g / L tetrabutylammonium hydrogen sulfate, the pH value of the tetrabutylammonium hydrogen sulfate is 9.5-10.5,
[0028] Mobile phase B: acetonitrile,
[0029] Flow rate: 0.3mL / min,
[0030] Injection volume: 5 μL,
[0031] Running time: 25min;
[0032] The elution gradient is:
[0033] ;
[0034] (2) Preparation of blank solution
[0035] Blank solution: water;
[0036] (3) Preparation of reference solution
[0037] Accurately weigh 12.5 mg of edetate disodium reference substance, place it in a 50 mL volumetric flask, dissolve and dilute to the mark with water, then accurately measure 5 mL of the above solution, place it in a 50 mL volumetric flask, dissolve and dilute to the mark with water, shake well, and obtain;
[0038] (4) Preparation of test solution
[0039] Accurately measure 1 mL of Cetirizine Hydrochloride Eye Drops, place in a 10 mL volumetric bottle, dissolve in water and dilute to the mark, shake well, and the solution is ready.
[0040] (5) Sample injection
[0041] Accurately measure 5 μL of blank solution, reference solution, and test solution, inject them into the liquid chromatograph, and record the chromatogram;
[0042] (6) Content calculation
[0043] The content of disodium edetate in the cetirizine hydrochloride eye drops is calculated by the peak area external standard method, and the calculation formula is as follows:
[0044] ,
[0045] A S : Peak area of disodium edetate in the test solution, M R1 :Sampling amount of reference substance / mg, C R :Content of reference substance, N S :Dilution multiple of test solution, A R1 :The average peak area of edetate disodium after 5 consecutive injections of the reference solution, M S : Sample volume of the test sample / mL, N R : Dilution multiple of reference solution.
[0046] The method described in the present invention for detecting the content of disodium edetate in cetirizine hydrochloride eye drops has the following advantages:
[0047] 1. It is not necessary to perform complexation pre-treatment on the reference solution and the test solution, which simplifies the preparation of the test solution and the reference solution, reduces the interference of the complexing agent on the auxiliary materials in the test solution, improves the accuracy of the detection method, and is beneficial to the quality control of cetirizine hydrochloride eye drops;
[0048] 2. This method has strong specificity, good repeatability, short running time, reliable detection method and saves detection costs. BRIEF DESCRIPTION OF THE DRAWINGS
[0049] Figure 1 is the chromatogram of elution gradient 1 of Example 1;
[0050] Figure 2 is the chromatogram of elution gradient 2 of Example 1;
[0051] Figure 3 Be the blank solution chromatogram of Example 3;
[0052] Figure 4 It is the blank auxiliary material solution chromatogram of Example 3;
[0053] Figure 5 The chromatogram of the reference solution 1-1 of Example 2;
[0054] Figure 6 This is the chromatogram of the test solution 1 of Example 4;
[0055] Figure 7 It is the standard curve diagram of Example 5;
[0056] Description of reference numerals: 1 is the peak of disodium edetate. DETAILED DESCRIPTION
[0057] For ease of understanding, the application will be described more fully below, and preferred embodiments of the application are provided. However, the application can be implemented in many different forms and is not limited to the embodiments described herein. On the contrary, the purpose of providing these embodiments is to make the understanding of the disclosure of the present invention more thorough and comprehensive. In the embodiment, if specific techniques or conditions are not indicated, the techniques or conditions described in the document in this area or according to the product specification are carried out. Reagents used or instruments that do not indicate manufacturers are conventional products that can be obtained through the market.
[0058] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those generally understood by those skilled in the art of the present invention. The terms used herein in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention. The term "and / or" used herein includes any and all combinations of one or more related listed items.
[0059] Example 1 Screening process of chromatographic conditions
[0060] 1. Selection of chromatographic column
[0061] The chromatographic columns commonly used in the detection method of disodium edetate content in the prior art are all octadecyl bonded silica gel columns. In order to shorten the injection time and improve the efficiency, the length, inner diameter and particle size of the chromatographic column are preferably small. Therefore, the chromatographic column used in this method is Poroshell HPH-C18, 3.0mm×100mm, 2.7μm.
[0062] 2. Selection of flow rate
[0063] According to the preliminarily planned inner diameter and particle size of the chromatographic column, the column pressure will be much greater than that of an ordinary C18 chromatographic column, so a low flow rate was selected for the experiment. This method preliminarily determined the flow rate to be 0.3 mL / min.
[0064] 3. Screening of mobile phase
[0065] The applicant found that tetrabutylammonium hydrogen sulfate can provide a stable pH value and ionic strength, thereby optimizing the separation effect. However, as the concentration of tetrabutylammonium hydrogen sulfate increases, its stability gradually decreases. Therefore, the mobile phase A used in this method is a 0.8-0.9 g / L tetrabutylammonium hydrogen sulfate solution.
[0066] 4. Screening of mobile phase pH value
[0067] For acidic compounds, the pH needs to be adjusted to a higher level; for alkaline compounds, the pH needs to be adjusted to a lower level, which is conducive to the full dissociation of the compound, and then combines with the ion pair reagent to form an ion pair. Disodium edetate is an acidic compound, so the mobile phase pH used in this method is 9.5~10.5.
[0068] 5. Column temperature selection
[0069] For compounds with high boiling points, a lower column temperature should be selected. Since the boiling point of disodium edetate is greater than 100°C, the column temperature used in this method is 20°C.
[0070] 6. Screening of elution methods
[0071] Because there are many types of excipients and interfering factors in the prescription of cetirizine hydrochloride eye drops, the selection of isocratic elution may result in poor separation effect. Gradient elution allows the composition and polarity of the mobile phase to be continuously changed during the separation process, thereby improving the separation effect. Therefore, the elution method used in this method is gradient elution.
[0072] Table 1 Elution gradient
[0073] ;
[0074] When gradient 1 was used, the peak of disodium edetate overlapped with the adjacent impurity peak and could not be separated. See the attached Figure 1Therefore, the gradient was adjusted to gradient 2 for the test. The separation degree between the disodium edetate peak and the adjacent impurity peak was 1.9, and separation was achieved. See the attached Figure 2 .
[0075] 7. Screening of test solution preparation methods
[0076] Two methods of direct injection and dilution of cetirizine hydrochloride eye drops were investigated. When directly injected, the tailing factor of the disodium edetate peak in the test solution was 1.7, and the number of theoretical plates was 3576, which did not meet the requirements; after 10-fold dilution, the tailing factor of the disodium edetate peak in the test solution was 1.3, and the number of theoretical plates was 11792, both of which met the requirements. The method for preparing the test solution is: accurately measure 1 mL of cetirizine hydrochloride eye drops, place it in a 10 mL volumetric flask, dissolve it in water and dilute it to the scale, shake it well, and you have it.
[0077] In addition, because edetate disodium is easily soluble in water and this product is also eye drops, water is used as a diluent.
[0078] Example 2 System suitability test
[0079] (1) Chromatographic conditions
[0080] Chromatographic column: Poroshell HPH-C18 (3.0mm×100mm, 2.7μm)
[0081] Detector: DAD;
[0082] Detection wavelength: 214nm;
[0083] Column temperature: 20°C;
[0084] Mobile phase A: 0.85 g / L tetrabutylammonium hydrogen sulfate (adjusted to pH 10.0 with aqueous ammonia);
[0085] Mobile phase B: acetonitrile;
[0086] Flow rate: 0.3 mL / min;
[0087] The elution gradient program was:
[0088] ;
[0089] (2) The solution is prepared as follows:
[0090] Blank solution: water
[0091] Reference solution: accurately weigh 12.5 mg of edetate disodium reference substance, place in a 50 mL volumetric flask, dissolve and dilute to the mark with water, then accurately weigh 5 mL of the above solution, place in a 50 mL volumetric flask, dissolve and dilute to the mark with water, and shake well;
[0092] (3) Accurately measure 5 μL of the blank solution and reference solution, inject them into the liquid chromatograph, inject the reference solution 1 5 times continuously, record the chromatogram, and calculate the peak area RSD of edetate disodium. The results are shown in Table 2;
[0093] Table 2 System suitability test results
[0094] ;
[0095] From the results in Table 2, it can be seen that the RSD (%) of the peak area of disodium edetate is ≤2.0%, and the system suitability meets the requirements.
[0096] Example 3 Specificity Test
[0097] (1) Chromatographic conditions
[0098] Same as Example 2;
[0099] (2) The solution is prepared as follows:
[0100] Blank solution: water
[0101] Blank excipient solution (cetirizine hydrochloride eye drops without edetate disodium): accurately measure 2 mL of blank excipient solution, place in a 20 mL volumetric flask, dissolve and dilute to the mark with water, and shake well;
[0102] (3) Accurately measure 5 μL of blank solution and blank excipient solution, inject them into the liquid chromatograph, and record the chromatogram. The results are shown in Table 3;
[0103] Table 3 Specificity determination results
[0104] ;
[0105] From Table 3, Appendix Figure 3 and attached Figure 4 It can be seen that the blank solution and blank excipient solution have no interference with the detection.
[0106] Example 4 Repeatability Test
[0107] (1) Chromatographic conditions
[0108] Same as Example 2;
[0109] (2) The solution is prepared as follows:
[0110] Test solution: Accurately measure 1 mL of cetirizine hydrochloride eye drops, place in a 10 mL volumetric flask, dissolve and dilute to the mark with water, shake well, and prepare 6 portions in the same way;
[0111] (3) Accurately measure 5 μL of each test solution, inject it into the liquid chromatograph, record the chromatogram, and calculate the content of disodium edetate. The results are shown in Table 4;
[0112] Table 4 Repeatability test results
[0113] ;
[0114] From the results in Table 4, it can be seen that the RSD (%) of the edetate disodium content (n=6) is ≤2.0%, and the repeatability of the method is good.
[0115] Example 5 Linearity Test
[0116] (1) Chromatographic conditions
[0117] Same as Example 2;
[0118] (2) The solution is prepared as follows:
[0119] Linear stock solution: Accurately weigh 12.5 mg of edetate disodium reference substance, place in a 50 mL volumetric flask, dissolve and dilute to the mark with water, and shake well;
[0120] 50% linear solution: accurately measure 1 mL of linear stock solution, place in a 20 mL volumetric flask, dissolve and dilute to the mark with water, and shake well;
[0121] 80% linear solution: accurately measure 2 mL of linear stock solution, place in a 25 mL volumetric flask, dissolve and dilute to the mark with water, and shake well;
[0122] 100% linear solution: accurately measure 5 mL of linear stock solution, place in a 50 mL volumetric flask, dissolve and dilute to the mark with water, and shake well;
[0123] 150% linear solution: accurately measure 3 mL of linear stock solution, place in a 20 mL volumetric flask, dissolve and dilute to the mark with water, and shake well;
[0124] 200% linear solution: accurately measure 5 mL of linear stock solution, place in a 25 mL volumetric flask, dissolve and dilute to the mark with water, and shake well;
[0125] (3) Accurately measure 5 μL of each of the above linear solutions, inject into the liquid chromatograph, record the chromatogram, and calculate the linear relationship between the peak area and concentration of edetate disodium. The results are shown in Table 5;
[0126] Table 5 Linearity determination results
[0127] ;
[0128] Note: Actual concentration = linear stock solution sample volume * reference substance content / dilution multiple;
[0129] Standard curve diagram, such as Figure 7As shown in Table 5, within the linear concentration range of 50% to 200%, the correlation coefficient of the linear equation is r≥0.999, and the linear relationship is good.
[0130] Example 6 Accuracy Test
[0131] (1) Chromatographic conditions
[0132] Same as Example 2;
[0133] (2) The solution is prepared as follows:
[0134] Reference substance stock solution: accurately weigh 12.5 mg of edetate disodium reference substance, place in a 50 mL volumetric flask, dissolve and dilute to the mark with water, and shake well;
[0135] Blank excipient solution: Accurately measure 5 mL of blank excipient solution, place in a 50 mL volumetric flask, dissolve and dilute to the mark with water, and shake well;
[0136] 50% accuracy solution: accurately measure 1 mL of reference stock solution and 2 mL of blank excipient solution, place in a 20 mL volumetric flask, dissolve and dilute to the mark with water, shake well, and prepare 3 portions in the same way;
[0137] 100% accuracy solution: accurately measure 2 mL of reference stock solution and 2 mL of blank excipient solution, place in a 20 mL volumetric flask, dissolve and dilute to the mark with water, shake well, and prepare 3 portions in the same way;
[0138] 150% accuracy solution: accurately measure 3 mL of reference stock solution and 2 mL of blank excipient solution, place in a 20 mL volumetric flask, dissolve and dilute to the mark with water, shake well, and prepare 3 portions in the same way;
[0139] (3) Accurately measure 5 μL of each of the above accuracy solutions, inject them into the liquid chromatograph, record the chromatogram, and calculate the recovery rate of the peak area of edetate disodium. The results are shown in Table 6;
[0140] Table 6 Accuracy test results
[0141] ;
[0142] From the results in Table 6, it can be seen that when the concentration of disodium edetate is within the range of 50% to 150%, the average recovery rate at each concentration is between 98.0% and 102.0%, and the recovery rate RSD is ≤2.0%. The accuracy of this method is good;
[0143] , ,
[0144] A S : Peak area of the main component in the accuracy solution, C R1: Concentration of reference solution 1 (μg / mL), A R1 : Average peak area of 5 consecutive injections of reference solution 1.
[0145] The above embodiments are only used to illustrate the technical solutions of the present invention and should not be used to limit the scope of the present invention. That is, any simple modifications made according to the claims of the present invention and the contents of the present invention description should fall within the scope covered by the patent of the present invention.
Claims
1. A method for detecting the content of disodium edetate in cetirizine hydrochloride eye drops, characterized in that: The cetirizine hydrochloride eye drops are analyzed by a high performance liquid chromatography analysis method to obtain a chromatogram, and based on the chromatogram, the content of disodium edetate in the cetirizine hydrochloride eye drops is determined, wherein the mobile phase A used in the high performance liquid chromatography analysis method is 0.8-0.9 g / L tetrabutylammonium hydrogen sulfate solution, and the mobile phase B is acetonitrile; the pH value of the mobile phase A is 9.5-10.5; the chromatographic column used in the high performance liquid chromatography is Poroshell HPH-C18, 3.0 mm×100 mm, 2.7 μm; the elution gradient used in the high performance liquid chromatography is: 。 2. The detection method according to claim 1, characterized in that: The pH value of the mobile phase A was adjusted using aqueous ammonia.
3. The detection method according to claim 1, characterized in that: The cetirizine hydrochloride eye drops are provided in the form of a test solution, wherein the test solution is an aqueous solution of cetirizine hydrochloride eye drops, and based on each milliliter of the test solution, the concentration of disodium edetate is 25 μg / mL.
4. The detection method according to claim 1, characterized in that: The detection of the content of disodium edetate in the cetirizine hydrochloride eye drops also requires the provision of a reference solution, wherein the reference solution is an aqueous solution of disodium edetate, and based on each milliliter of the reference solution, the concentration of disodium edetate is 25 μg / mL.
5. The detection method according to claim 1, characterized in that: The detection wavelength adopted by the high performance liquid chromatography is 214 nm.
6. The detection method according to claim 1, characterized in that: The column temperature used in the HPLC was 20°C.
7. The detection method according to claim 1, characterized in that: Based on the chromatogram, the content of disodium edetate in the cetirizine hydrochloride eye drops was determined by calculating the peak area external standard method, and the calculation formula is as follows: , A S : Peak area of disodium edetate in the test solution, M R1 :Sampling amount of reference substance / mg, C R :Content of reference substance, N S :Dilution times of test solution, A R1 :The average peak area of edetate disodium after 5 consecutive injections of the reference solution, M S : Sample volume of the test sample / mL, N R : Dilution multiple of reference solution.
8. The detection method according to any one of claims 1 to 7, characterized in that: include: (1) Chromatographic conditions Chromatographic column: Poroshell HPH-C18, 3.0mm×100mm, 2.7μm, Detector: DAD, Detection wavelength: 214nm, Column temperature: 20°C, Mobile phase A: 0.8-0.9 g / L tetrabutylammonium hydrogen sulfate, the pH of the tetrabutylammonium hydrogen sulfate is 9.5-10.5, Mobile phase B: acetonitrile, Flow rate: 0.3mL / min, Injection volume: 5 μL, Running time: 25min; The elution gradient is: ; Running time: 25min; (2) Preparation of blank solution Blank solution: water; (3) Preparation of reference solution Accurately weigh 12.5 mg of edetate disodium reference substance, place it in a 50 mL volumetric flask, dissolve and dilute to the mark with water, then accurately measure 5 mL of the above solution, place it in a 50 mL volumetric flask, dissolve and dilute to the mark with water, shake well, and obtain; (4) Preparation of test solution Accurately measure 1 mL of Cetirizine Hydrochloride Eye Drops, place in a 10 mL volumetric bottle, dissolve in water and dilute to the mark, shake well, and the solution is ready. (5) Sample injection Accurately measure 5 μL of blank solution, reference solution, and test solution, inject them into the liquid chromatograph, and record the chromatogram; (6) Content calculation The content of disodium edetate in the cetirizine hydrochloride eye drops is calculated by the peak area external standard method, and the calculation formula is as follows: , A S : Peak area of disodium edetate in the test solution, M R1 :Sampling amount of reference substance / mg, C R :Content of reference substance, N S :Dilution times of test solution, A R1 :The average peak area of edetate disodium after 5 consecutive injections of the reference solution, M S : Sample volume of the test sample / mL, N R : Dilution multiple of reference solution.
Citation Information
Patent Citations
Method for determining disodium ethylene diamine tetraacetate in tafluprost eye drops
CN111398443A
Method for determining content of edetate disodium in desloratadine oral solution
CN114487192A
Method for measuring content of edetate disodium in metronidazole gel
CN116482259A
Determining method for EDTA-2Na content in terbutaline sulfate atomized solution
CN110118842A
Levocetirizine hydrochloride eye drops and preparation method thereof
CN113876702A
